Larry Ellison is investing up to $165 million to turn University of Oxford science research ...
Larry Ellison's $165 million Oxford investment aims to transform research into products, in areas including health and clean ...
Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
New Deloitte Survey: Increasing Consumer Privacy and Security Concerns in the Generative AI Era
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
Le Lézard35 分钟
BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S ...
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it has received Notice of Allowance from the U.S. Patent & ...